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Abstract
Background: There has been an expansion of circumcision services in Africa as part of a long-term HIV prevention
strategy. However, the effect of infant male circumcision on morbidity and mortality still remains unclear. Acute
morbidities associated with circumcision include pain, bleeding, swelling, infection, tetanus or inadequate skin
removal. Scale-up of circumcision services could lead to a rise in these associated morbidities that could have
significant impact on health service delivery and the safety of infants.
Multidisciplinary training programmes have been developed to improve skills of health service providers, but very
little is known about the effectiveness of health service provider education and/or training for infant male circumcision
on short- and long-term morbidity outcomes. This review aims to evaluate the effectiveness of health service provider
education and/or training for infant male circumcision on short- and long-term morbidity outcomes.
Methods/design: The review will include studies comparing health service providers who have received education
and/or training to improve their skills for infant male circumcision with those who have not received education and/or
training. Randomised controlled trials (RCTs) and cluster RCTs will be included. The outcomes of interest are short-term
morbidities of the male infant including pain, infection, tetanus, bleeding, excess skin removal, glans amputation and
fistula. Long-term morbidities include urinary tract infection (UTI), HIV infection and abnormalities of urination. Databases
such as MEDLINE (OVID), PsycINFO (OVID), EMBASE (OVID), CINAHL, Cochrane Library (including CENTRAL and DARE),
WHO databases and reference list of papers will be searched for relevant articles. Study selection, data extraction and
synthesis and risk of bias assessment using the Cochrane risk of bias assessment tool will be conducted. We will calculate
the pooled estimates of the difference in means and risk ratios using random effects models. If insufficient data are
available, we will present results descriptively.
Discussion: This review appears to be the first to be conducted in this area. The findings will have important
implications for infant male circumcision programmes and policy.
Systematic review registration: PROSPERO CRD42015029345
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Background
There has been an expansion of circumcision services in
areas of Africa as part of the long-term human immuno-
deficiency virus (HIV) prevention strategy. This has been
initiated from the results of three randomised controlled
trials that showed a 60 % protective effect of circumcision
during adulthood on HIV acquisition [1–4]. Despite the
outcomes of these previous randomised controlled trials
(RCTs), the effect of infant male circumcision on HIV risk
still remains unclear. Acute morbidities associated with
circumcision also include pain, bleeding, swelling, infec-
tion, tetanus or inadequate skin removal. With increased
circumcision rates, there is potential for a rise in these as-
sociated morbidities that could have a substantial impact
on health service delivery and patient safety.
Infant male circumcision is commonly practiced in
many parts of the world, by both formal health service
providers such as doctors/surgeons, medical assistants,
midwives/nurses and informal health service providers
including traditional circumcision providers, traditional
birth attendants, religious leaders, traditional medicine
men/women and other health staff. As a surgical proced-
ure, it is expected that male circumcision be performed
at the required standard by all circumcision service pro-
viders with the requisite training. For example, health
service providers need to be trained on the following:
how to perform circumcision in aseptic conditions, use
of equipment and tools, measures to reduce morbidity,
follow-up care and education to families. Yet, health ser-
vice providers often do not receive the required training
and education to perform these operations to an optimal
standard resulting in complications ranging from 1.7 to
7.6 % [5] following infant male circumcision.
A recent prospective study of complications of neonatal
circumcision in Nigeria found that complications due to
male circumcision was 10.9 % and, as a result, has recom-
mended training of health service providers to reduce the
rate of complications [6]. Another study conducted in the
USA among doctors performing neonatal circumcision
also indicated the lack of structured training on neonatal
circumcision for doctors. The study attributed the high
complication rate and poor paediatric urology results to
uncoordinated and informal training schemes for doctors
who performed neonatal circumcisions. This study also
recommended structured and formal training as strategy
to reduce complications associated with infant male cir-
cumcisions [7].
It is expected that morbidities associated with infant cir-
cumcision could be reduced if health service providers are
given the necessary education and/or training to perform
the circumcision. Several training programmes have been
developed to improve the skills of health service providers
among diverse health interventions. What is not yet clear
is whether the provision of education and/or training
would improve health service provider skills in infant male
circumcision leading to reduced rates of short- and long-
term morbidity outcomes.
There has yet to be a systematic review on this topic. A
recent Cochrane review in 2012 examined the effects of
routine neonatal circumcision for the prevention of urin-
ary tract infections (UTIs) in infancy. In this review, no
RCT, cluster RCT or quasi-RCTs was located [8]. Another
systematic review that assessed RCTs of interventions to
improve the safety and efficacy of nontherapeutic male
circumcision of any age was conducted in 2010, and eight
RCTs were located. Only two of the studies were con-
ducted among infants. The review did not find any studies
that reported on infant circumcision and sexually trans-
mitted infection, penile cancer, UTIs or HIV/AIDS [9].
In 2008, the World Health Organization (WHO)
Department of Reproductive Health and Research funded
two workshops to document infant circumcision practices
in Africa [10]. One recommendation from the workshops
was that further study of current infant circumcision prac-
tices was needed to inform the development of circumci-
sion policies. As infant male circumcision services are
being promoted in areas of Africa, our review will help to
provide an understanding of the current literature and
gaps on the effect of health service provider education
and/or training for infant male circumcision on short- and
long-term morbidity outcomes.
Objectives
The primary aim of the review is to assess the effective-
ness of health service provider education and/or training
in infant male circumcision on morbidity or mortality
outcomes in any setting.
Review question
What is the effectiveness of health service provider edu-
cation and/or training in infant male circumcision on
morbidity or mortality outcomes in any setting?
Methods/design
Protocol development
We developed the systematic review protocol based on
recommendations of the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses Protocols
(PRIMSA-P) statement [11] and provided a populated
checklist in Additional file 1. The review protocol was
revised by the authors and is registered on the PROS-
PERO database (CRD42015029345 which is available
at http://www.crd.york.ac.uk/prospero/display_record.asp?
ID=CRD42015029345).
Types of studies
RCTs and cluster-RCTs will be included for the review.
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If possible, we will include published abstracts if there
is sufficient information to allow us to assess study eligi-
bility and risk of bias. If sufficient information is not
available, the study would await assessment pending the
publication of the full trial report or the provision of fur-
ther information by trial authors.
Participants
Formal and informal health service providers will be in-
cluded. Formal health service providers are profession-
ally trained, licensed and regulated providers of medical
services and include the following:
 Doctor
 Surgeon
 Medical assistant
 Midwife
 Nurse.
Informal health service providers are untrained,
unlicensed, unregulated or informal private providers of
medical services and include the following:
 Traditional circumcision providers
 Traditional birth attendants
 Religious leaders
 Traditional medicine men/women
 Other health facility staff.
Health service providers will be excluded if they are
undergoing medical training.
Types of interventions
Intervention
The intervention is an additional education and/or train-
ing to improve health service provider skills in infant male
circumcision. Training could be peer-to-peer, hands-on
experience, lectures, practical training, demonstrations,
small-group discussions, structured training, e.g. didactic
learning, or simulation training. Training could occur in
any environment, e.g. hospital, clinic, family homes or
provider’s homes. Education could include topics on
how to perform circumcision, use of equipment, how to
ensure sterility, morbidity control, communication and
follow-up care.
Control condition
There are two different types of control groups: (i) health
service providers who have not received education and/or
training and (ii) health service providers who have re-
ceived standard education and/or training.
Studies of complex training interventions (in which
training is combined with a larger health system interven-
tion) will be excluded.
Types of outcome measures
Our main (primary) outcomes are as follows:
 Short- and long-term all-cause morbidities which
may include pain, bleeding, excess skin removal,
glans amputation, fistula, infection, tetanus, urinary
tract infection (UTI), HIV infection, abnormalities
of urination and other identified morbidities.
 All-cause mortality.
Short-term morbidity is defined as a morbidity occur-
ring within 6 months of the circumcision procedure.
Long-term morbidity is defined as greater than 6 months
from the time of the circumcision procedure.
Our secondary outcomes are defined as follows:
 Presentations to clinic or hospital
 Family satisfaction
 Health service provider satisfaction
 Skill improvement in health service provider
 Knowledge improvement in health service providers
 Training costs.
Search strategy
The databases to be used for searching the relevant trials
include the Cochrane Central Register of Controlled Tri-
als (CENTRAL) (The Cochrane Library), MEDLINE
(Ovid), EMBASE (Ovid), and Cochrane Database of Sys-
tematic Reviews and Database of Abstracts of Reviews of
Effects (DARE). An example of the MEDLINE search
strategy is in Additional file 2.
The clinical trial registries include the following: Clinical-
Trials.gov (http://clinicaltrials.gov/), International Standard
Randomised Controlled Trial Number (ISRCTN) (http://
www.controlled-trials.com), WHO International Clinical
Trials Registry Platform (http://who.int/ictrp/en/) and UK
Clinical Research Network Study Portfolio (http://publi-
c.ukcrn.org.uk/search/).
The search period will be from 1985 to 2015 in all lan-
guages. Translation assistance will be sought.
Searching other sources
We will hand search reference lists from relevant articles
chosen for potential inclusion in this review to identify
further relevant studies. We will contact authors of in-
cluded studies to determine whether there are any add-
itional studies published, ongoing or unpublished that
may be relevant.
Study selection
All review titles and abstracts retrieved through the
search strategy will be reviewed independently by two
authors to identify studies that meet the inclusion cri-
teria. Inclusion criteria at the title and abstract review
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level will be limited to any primary study (quantita-
tive) reporting on intervention with focus on health
service provider’s education and/or training to im-
prove provider skills on infant male circumcision. Ex-
clusion criteria will include infants greater than
12 months, review articles, qualitative and opinion ar-
ticles. Once articles have been identified, full-text arti-
cles will be retrieved and independently assessed by
two independent review authors. For any disagree-
ment, a third reviewer will be asked to assess the trial
to determine eligibility for inclusion in the review. Au-
thors will also be contacted for further clarification if
necessary. We will document reasons for exclusion,
and reference manager Endnote X7 will be used dur-
ing this selection process.
Data extraction and management
A data extraction form will be developed and pre-
tested before it will be used to extract data from the eli-
gible studies. Two review authors will independently
extract data from the included studies. Any disagree-
ment between the two authors will be discussed. Fur-
ther disagreement will be resolved through discussion
with a third reviewer. Retrieved information will be
considered based on context, intervention and outcome
and includes the following.
Methodology
 Type of randomisation
 Study setting
 Recruitment
 Loss to follow-up rates
Study population
 Participant’s demographics
Interventions
 Description of the intervention and control groups
Outcomes
 Primary and secondary outcomes
 Time points of measurements
 Indicators of assessment of risk of bias
Authors
 Study funding
Notes
 Any information by the authors that may be useful
Non-English language articles will be translated. Authors
will be contacted for additional information if required. All
disclaimer statements will be assessed.
Risk of bias assessment
The Cochrane risk of bias assessment tool [12] will be
used to assess the risk of eligible studies by two review
authors. In case of disagreement, the third author will be
involved in the assessment and resolution of the risk of
bias assessments. The assessment will be categorised as ei-
ther low, high or unclear risk of bias with explanation for
each domain. The risk of bias domains include random se-
quence generation (selection bias), allocation concealment
(selection bias), blinding of participants and personnel
(performance bias), blinding of outcome assessment (de-
tection bias), incomplete outcome data (attrition bias), se-
lective reporting (reporting bias) and other bias.
Authors will be contacted to provide additional infor-
mation if data for assessment of risk of bias from eligible
studies is inadequate. These data will be included in the
data extraction processes. We will not exclude studies
based on risk of bias assessment. The information will
be used in the analysis and report of the review findings.
Overall risk of bias
The risk of bias summary tool will be used to collate the
risk of bias for all eligible studies. Studies with a high or
unclear risk of bias in the domain for sequence gener-
ation, similarity of baseline outcome measurements, com-
pleteness of outcome data and other risks of bias will be
considered high risk. Conclusions will also take into ac-
count the impact of the bias and whether it is likely to bias
the findings of the study.
Measures of treatment effect
Data will be entered into RevMan 5.3 software. Risk ratios
(RR) and 95 % confidence intervals will be calculated for
dichotomous data including the proportion of infants re-
ported as having short- or long-term morbidity outcomes,
infant mortality, presentations to clinic or hospital, skill
improvement as a result of the intervention, and train-
ing costs.
We will report mean difference (MD) for continuous
outcomes and standardised mean difference (SMD) if dif-
ferent scales are used (such as family satisfaction, health
service provider satisfaction and increased knowledge)
with 95 % confidence intervals for outcomes in each of
the studies. The level of significance will be provided in
case the above is not available. Chi-square test will be used
to assess heterogeneity.
Unit of analysis
It is possible that cluster RCTs may be included in this
review. If they are to be included in the meta-analysis,
we will first determine if the authors have appropriately
controlled for effects of clustering in the study. If there is
doubt, the authors will be contacted for clarification. If the
error has not been corrected and the data are available, we
will derive an estimate of the intracluster correlation coef-
ficient (ICC) from the study. If the data are not available,
we will determine the ICC using a similar trial or from a
study with a similar population.
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We will report whether an ICC has been used and con-
duct a sensitivity analysis to determine the effect of using
an ICC. If the clustering has been accounted for, we will
determine whether this has been adequately completed.
Where authors have controlled for clustering, there is lit-
tle difference between the study designs or where there is
unlikely to be an interaction between the effect of the
intervention and the choice of randomisation method, the
data from cluster RCTs may then be combined with data
from individual RCTs. If we are unable to adjust for incor-
rect statistical methods used by the cluster trials and can-
not estimate the ICC with any a degree of confidence, we
will exclude the trial [12].
Dealing with missing data
We will attempt to contact authors by email for any
missing data.
Assessment of heterogeneity
We will construct forest plots to examine heterogeneity
between interventions and quantify the impact of the
heterogeneity using the I2 and chi-square statistics. If we
identify a substantial level of heterogeneity in trials (for
example, the I2 is more than 30 to 60 %, the P value is
less than 0.10 in the chi-square test for heterogeneity or
there is a different magnitude and direction of effects),
we will perform subgroup analyses to explore the pos-
sible causes of statistical heterogeneity [12] .
Assessment of reporting biases
If we are able to pool more than ten trials, we will create
and examine a funnel plot to explore possible small
study effects and publication biases.
Data synthesis
Where data is available, we will perform a single meta-
analysis for each outcome using RevMan 5.3 software. For
each outcome, we will firstly group by the type of control
and analyse each group separately. If there are no differ-
ences, we will combine the two groups for an overall ana-
lysis. For quantitative data, we will calculate the pooled
estimates of the SMDs or MDs and 95 % confidence inter-
vals using the random effects model. We will also calcu-
late pooled RR estimates and 95 % confidence intervals
using the random effects model. Where statistical pooling
is not possible, the findings will be analysed descriptively.
Assessing methodological quality
We will use the Grades of Recommendation, Assess-
ment, Development, and Evaluation (GRADE) approach
to assess the quality of the outcomes reported in this
review [13].
Subgroup analysis and heterogeneity
We will undertake subgroup analysis for the primary
outcome measures if significant heterogeneity is iden-
tified in the trials for the following categories: formal
and informal health service providers and low-, mid-
dle- and high-income countries. PROGRESS-Plus is an
assessment of participant’s socio-demographic charac-
teristics and subgroup outcomes (including socio-
economic status, provider education, occupation of
provider, ethnicity, religion) [14], settings of procedure,
location of provider, risk groups of health system non-
regulation or recognition, such as informal providers
particularly traditional providers.
Sensitivity analysis
We planned to conduct sensitivity analysis to assess the
impact of excluding studies with a high risk of bias as-
sessment on the primary outcomes.
Discussion
The findings of our review will have significant implica-
tions for infant male circumcision programmes and pol-
icy in any setting. Both formal and informal health
service providers will continue to play important roles in
the provision of infant male circumcision services glo-
bally. The association between poverty, infant health sta-
tus and access to appropriate health care is relevant for
decisions regarding the education and/or training to im-
prove health service provider skills on infant circumci-
sion to reduce morbidity in any setting. In settings
where there are few formal health service providers and/
or poor access to health facilities and families continue
to seek services from diverse health service providers,
education and/or training may be an effective way to re-
duce both short- and long-term morbidity outcomes.
Similarly, in places where access and high-quality health
service system are available but families decide to rely
on diverse health service providers for services, educa-
tion and/or training and structured collaboration with
the health system may be an effective way to reduce
morbidity associated with infant male circumcision.
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